FormsNet3 - Blank Form


 
 
Sequence Number:    

 
 
Date Received: __ __ __ __ - __ __- __ __  

 
 
CIBMTR Center Number:    

 
 
CIBMTR Recipient ID:    

 
 
Today's Date: __ __ __ __ - __ __- __ __  

 
 
Date of HSCT for which this form is being completed: __ __ __ __ - __ __- __ __  

 

HSCT type (check all that apply): 

 
  

gfedcb
Autologous

 
 

  
gfedcb

Allogeneic, unrelated

 
 

  
gfedcb

Allogeneic, related

 
 

  
gfedcb

Syngeneic (identical twin)

 

Product type (check all that apply): 

 
  

gfedcb
Marrow

 
 

  
gfedcb

PBSC

 
 

  
gfedcb

Cord blood

 
 

  
gfedcb

Other product

 
 
Specify:    

 
 

  
gfedcb

If this is a report of a second or subsequent transplant, check here and continue with question 180.

 
 
1  What was the date of diagnosis of Systemic Sclerosis (SSc)? __ __ __ __ - __ __- __ __  

 
 

2  What was the extent of cutaneous systemic sclerosis at diagnosis?

    
 nmlkji

limited (cutaneous thickening distal (but not proximal) to elbows or knees)  

 nmlkji
diffuse  

 nmlkji
Unknown  

 

Report findings prior to any first treatment for systemic sclerosis. 
 
3  Date CBC tested: __ __ __ __ - __ __- __ __  

 
 

4  WBC:

    
 nmlkji

Known  
 nmlkji

Not known  

  
 
5  .    

 

 nmlkji
x 109/L (x 103/mm3)  

 nmlkji
x 106/L  

 
 

6  Hemoglobin:

    
 nmlkji

Known  
 nmlkji

Not known  

  
 
7  .    

 

 nmlkji
g/dL  

 nmlkji
g/L  

 nmlkji
mmol/L  

 
 

8  Hematocrit:

    
 nmlkji

Known  
 nmlkji

Not known  

 
 
9     % 

  Key Fields 

Disease Assessment at Diagnosis Questions: 1 - 2

  Laboratory Studies at Diagnosis Questions: 3 - 29

Form 2044 R2.0: Systemic Sclerosis Pre-HSCT Data  
Center:  CRID: 

                 CIBMTR Form 2044 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 1 / 17



 
 

10  Platelets:

    
 nmlkji

Known  
 nmlkji

Not known  

  
 
11  .    

 

 nmlkji
x 109/L (x 103/mm3)  

 nmlkji
x 106/L  

 
 

12  Serum creatinine:

    
 nmlkji

Known  
 nmlkji

Not known  

  
 
13  .    

 

 nmlkji
mg/dL  

 nmlkji
mmol/L  

 nmlkji
µmol/L  

 
 

14  Creatinine clearance:

    
 nmlkji

Known  
 nmlkji

Not known  

  
 
15  .    

 

 nmlkji
mL/min  

 nmlkji
mL/sec  

 
 

16  Creatinine phosphokinase:

    
 nmlkji

Known  
 nmlkji

Not known  

  
 
17  .    

 

 nmlkji
U/L  

 nmlkji
µkat/L  

 
 

18  Blood urea nitrogen:

    
 nmlkji

Known  
 nmlkji

Not known  

  
 
19  .    

 

 nmlkji
mg/dL  

 nmlkji
mmol/L  

 
 

20  Was there evidence of hematuria at diagnosis?

    
 nmlkji

yes, present  
 nmlkji

no, absent  
 nmlkji

Unknown  

 
 

21  Was there evidence of proteinuria at diagnosis?

    
 nmlkji

yes, present  
 nmlkji

no, absent  
 nmlkji

Unknown  

 
 

22  Thyroid stimulating hormone (TSH):

    
 nmlkji

Known  
 nmlkji

Not known  

  
 
23  .    

 

 nmlkji
mU/L  

 nmlkji
μU/ml  

 
 

24  Was any testing for autoantibodies performed at diagnosis?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 

Specify the test results for the following autoantibodies: 
 

25  Anti-centromere:

    
 nmlkji

Positive  
 nmlkji

Negative  
 nmlkji

Inconclusive  
 nmlkji

not tested / unknown  

 
 

26  Anti-DNA topoi- 
somerase I (Scl-70):

    
 nmlkji

Positive  
 nmlkji

Negative  
 nmlkji

Inconclusive  
 nmlkji

not tested / unknown  

 
 

27  Anti-nuclear:

    
 nmlkji

Positive  
 nmlkji

Negative  
 nmlkji

Inconclusive  
 nmlkji

not tested / unknown  

 
 

28  Anti-SS-A:

    
 nmlkji

Positive  
 nmlkji

Negative  
 nmlkji

Inconclusive  
 nmlkji

not tested / unknown  

Form 2044 R2.0: Systemic Sclerosis Pre-HSCT Data  
Center:  CRID: 

                 CIBMTR Form 2044 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 2 / 17



 
 

29  Anti-SS-B:

    
 nmlkji

Positive  
 nmlkji

Negative  
 nmlkji

Inconclusive  
 nmlkji

not tested / unknown  

 
30  Did the recipient receive any disease-modifying treatments between the time of diagnosis and prior to mobilization for stem cell collection (or high dose therapy if mobilization was 

not done)? 

    
 nmlkji

yes  
 nmlkji

no  

 
 

31  Antithymocyte globulin (ATG) / antilymphocyte globulin (ALG)

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

32  Treatment Stopped

    
 nmlkji

yes  
 nmlkji

no  

 
 
33  Stopped Code:   

 
 
34  Specify:    

 
 

35  Cyclophosphamide (CTX, Cytoxan, Neosar)

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

36  Treatment Stopped

    
 nmlkji

yes  
 nmlkji

no  

 
 
37  Stopped Code:   

 
 
38  Specify:    

 
 

39  Cyclosporine (CsA, Neoral, Sandimmune)

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

40  Treatment Stopped

    
 nmlkji

yes  
 nmlkji

no  

 
 
41  Stopped Code:   

 
 
42  Specify:    

 
 

43  D-penicillamine (penicillamine, Cuprimine, Depen)

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

44  Treatment Stopped

    
 nmlkji

yes  
 nmlkji

no  

 
 
45  Stopped Code:   

 
 
46  Specify:    

 
 

47  Methotrexate (MTX, Folex)

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

48  Treatment Stopped

    
 nmlkji

yes  
 nmlkji

no  

 
 
49  Stopped Code:   

 
 
50  Specify:    

 
 
51    

gfedcb
Maximum weekly dose unknown:

 
 
Specify the maximum weekly dose:    mg 

 
 
52    

gfedcb
Duration of therapy unknown:

  
 
Specify the duration of therapy:    

 

 nmlkji
weeks  

 nmlkji
months  

  Pre-HSCT Treatment for Systemic Lupus Erythematosus Questions: 30 - 81

Form 2044 R2.0: Systemic Sclerosis Pre-HSCT Data  
Center:  CRID: 

                 CIBMTR Form 2044 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 3 / 17



 
 

53  Mycophenolate Mofetil (MMF, CellCept)

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

54  Treatment Stopped

    
 nmlkji

yes  
 nmlkji

no  

 
 
55  Stopped Code:   

 
 
56  Specify:    

 
 

57  Non-steroidal anti-inflammatory drugs (NSAIDS)

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

58  Treatment Stopped

    
 nmlkji

yes  
 nmlkji

no  

 
 
59  Stopped Code:   

 
 
60  Specify:    

 
 

61  Phototherapy

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

62  Treatment Stopped

    
 nmlkji

yes  
 nmlkji

no  

 
 
63  Stopped Code:   

 
 
64  Specify:    

 
 

65  Prednisone (Intensol, Sterapred) or equivalent

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

66  Treatment Stopped

    
 nmlkji

yes  
 nmlkji

no  

 
 
67  Stopped Code:   

 
 
68  Specify:    

 
 

69  Prostanoids / prostaglandin analogs

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

70  Treatment Stopped

    
 nmlkji

yes  
 nmlkji

no  

 
 
71  Stopped Code:   

 
 
72  Specify:    

 
 

73  Tacrolimus (FK 506, Prograf)

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

74  Treatment Stopped

    
 nmlkji

yes  
 nmlkji

no  

 
 
75  Stopped Code:   

 
 
76  Specify:    

 
 

77  Other treatment

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

78  Treatment Stopped

    
 nmlkji

yes  
 nmlkji

no  

 
 
79  Stopped Code:   

Form 2044 R2.0: Systemic Sclerosis Pre-HSCT Data  
Center:  CRID: 

                 CIBMTR Form 2044 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 4 / 17



 
 
80  Specify:    

 
 
81  Specify other treatment:    

 

  

gfedcb
Information for this section should come from the most recent evaluation prior to the initiation of mobilization therapy (<= 4 weeks prior to mobilization for stem cell collection). If the 
recipient did not receive mobilization therapy, check here and continue with question 180. 

 
 
82  Date of evaluation prior to mobilization for stem cell collection: __ __ __ __ - __ __- __ __  

 
 

83  What was the extent of cutaneous systemic sclerosis prior to mobilization for stem cell collection?

    
 nmlkji

limited (cutaneous thickening distal (but not proximal) to elbows or knees)  

 nmlkji
diffuse  

 nmlkji
Unknown  

 

Specify skin thickness for the following sites as determined by clinical palpation performed prior to mobilization for stem cell collection: Clements P, Lachenbruch P, Seibold J, 

White B, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995; 22:1281-

1285.  
 

84  Face

    
 nmlkji

score 0   - Normal 

 nmlkji
score 1   - Mild 

 nmlkji
score 2   - Moderate 

 nmlkji
score 3   - Severe (inability to pinch skin into a fold) 

 
 

85  Anterior chest

    
 nmlkji

score 0   - Normal 

 nmlkji
score 1   - Mild 

 nmlkji
score 2   - Moderate 

 nmlkji
score 3   - Severe (inability to pinch skin into a fold) 

 
 

86  Abdomen

    
 nmlkji

score 0   - Normal 

 nmlkji
score 1   - Mild 

 nmlkji
score 2   - Moderate 

 nmlkji
score 3   - Severe (inability to pinch skin into a fold) 

 
 

87  Upper arm - left

    
 nmlkji

score 0   - Normal 

 nmlkji
score 1   - Mild 

 nmlkji
score 2   - Moderate 

 nmlkji
score 3   - Severe (inability to pinch skin into a fold) 

 
 

88  Upper arm - right

    
 nmlkji

score 0   - Normal 

 nmlkji
score 1   - Mild 

 nmlkji
score 2   - Moderate 

 nmlkji
score 3   - Severe (inability to pinch skin into a fold) 

  Disease Assessment Prior to Mobilization Therapy for Stem Cell Collection Questions: 82 - 114

Form 2044 R2.0: Systemic Sclerosis Pre-HSCT Data  
Center:  CRID: 

                 CIBMTR Form 2044 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 5 / 17



 
 

89  Forearm-left

    
 nmlkji

score 0   - Normal 

 nmlkji
score 1   - Mild 

 nmlkji
score 2   - Moderate 

 nmlkji
score 3   - Severe (inability to pinch skin into a fold) 

 
 

90  Forearm-right

    
 nmlkji

score 0   - Normal 

 nmlkji
score 1   - Mild 

 nmlkji
score 2   - Moderate 

 nmlkji
score 3   - Severe (inability to pinch skin into a fold) 

 
 

91  Dorsum of hand - left

    
 nmlkji

score 0   - Normal 

 nmlkji
score 1   - Mild 

 nmlkji
score 2   - Moderate 

 nmlkji
score 3   - Severe (inability to pinch skin into a fold) 

 
 

92  Dorsum of hand - right

    
 nmlkji

score 0   - Normal 

 nmlkji
score 1   - Mild 

 nmlkji
score 2   - Moderate 

 nmlkji
score 3   - Severe (inability to pinch skin into a fold) 

 
 

93  Fingers - left

    
 nmlkji

score 0   - Normal 

 nmlkji
score 1   - Mild 

 nmlkji
score 2   - Moderate 

 nmlkji
score 3    - Severe (inability to pinch skin into a fold) 

 
 

94  Fingers - right

    
 nmlkji

score 0   - Normal 

 nmlkji
score 1   - Mild 

 nmlkji
score 2   - Moderate 

 nmlkji
score 3   - Severe (inability to pinch skin into a fold) 

 
 

95  Thigh - left

    
 nmlkji

score 0   - Normal 

 nmlkji
score 1   - Mild 

 nmlkji
score 2   - Moderate 

 nmlkji
score 3   - Severe (inability to pinch skin into a fold) 

Form 2044 R2.0: Systemic Sclerosis Pre-HSCT Data  
Center:  CRID: 

                 CIBMTR Form 2044 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 6 / 17



 
 

96  Thigh - right

    
 nmlkji

score 0   - Normal 

 nmlkji
score 1   - Mild 

 nmlkji
score 2   - Moderate 

 nmlkji
score 3   - Severe (inability to pinch skin into a fold) 

 
 

97  Lower leg - left

    
 nmlkji

score 0   - Normal 

 nmlkji
score 1   - Mild 

 nmlkji
score 2   - Moderate 

 nmlkji
score 3   - Severe (inability to pinch skin into a fold) 

 
 

98  Lower leg - right

    
 nmlkji

score 0   - Normal 

 nmlkji
score 1   - Mild 

 nmlkji
score 2   - Moderate 

 nmlkji
score 3   - Severe (inability to pinch skin into a fold) 

 
 

99  Dorsum of foot - left

    
 nmlkji

score 0   - Normal 

 nmlkji
score 1   - Mild 

 nmlkji
score 2   - Moderate 

 nmlkji
score 3   - Severe (inability to pinch skin into a fold) 

 
 

100  Dorsum of foot - right

    
 nmlkji

score 0   - Normal 

 nmlkji
score 1   - Mild 

 nmlkji
score 2   - Moderate 

 nmlkji
score 3   - Severe (inability to pinch skin into a fold) 

 
 
101  Total modified Rodnan Skin Score: (add scores from questions 84-100)    

 

Specify the following clinical findings prior to mobilization for stem cell collection: 
 

102  Changes in skin pigmentation:

    
 nmlkji

Present  
 nmlkji

Absent  
 nmlkji

Unknown  

 
 

103  Raynaud's phenomenon:

    
 nmlkji

Present  
 nmlkji

Absent  
 nmlkji

Unknown  

 
 

104  Painful digital ulcers:

    
 nmlkji

Present  
 nmlkji

Absent  
 nmlkji

Unknown  

 
 
105  Specify number of digital ulcers:    

 
 

106  Gut dysmotility

    
 nmlkji

Present  
 nmlkji

Absent  
 nmlkji

Unknown  

Form 2044 R2.0: Systemic Sclerosis Pre-HSCT Data  
Center:  CRID: 

                 CIBMTR Form 2044 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 7 / 17



 
 

107  Malabsorption:

    
 nmlkji

Present  
 nmlkji

Absent  
 nmlkji

Unknown  

 
 

108  Weight loss > 10% of body weight:

    
 nmlkji

Present  
 nmlkji

Absent  
 nmlkji

Unknown  

 
 

109  Muscle weakness:

    
 nmlkji

Present  
 nmlkji

Absent  
 nmlkji

Unknown  

 
 

110  Joint tenderness:

    
 nmlkji

Present  
 nmlkji

Absent  
 nmlkji

Unknown  

 
 
111  Specify number of joints affected:    

 
 

112  Tendon friction rubs:

    
 nmlkji

Present  
 nmlkji

Absent  
 nmlkji

Unknown  

 
 
113  Specify number of sites affected:    

 
 

114  Contractures:

    
 nmlkji

Present  
 nmlkji

Absent  
 nmlkji

Unknown  

 
 
115  Date CBC tested: __ __ __ __ - __ __- __ __  

 
 

116  WBC:

    
 nmlkji

Known  
 nmlkji

Not known  

  
 
117  .    

 

 nmlkji
x 109/L (x 103/mm3)  

 nmlkji
x 106/L  

 
 

118  Hemoglobin:

    
 nmlkji

Known  
 nmlkji

Not known  

  
 
119  .    

 

 nmlkji
g/dL  

 nmlkji
g/L  

 nmlkji
mmol/L  

 
 

120  Hematocrit:

    
 nmlkji

Known  
 nmlkji

Not known  

 
 
121  .    % 

 
 

122  Platelets:

    
 nmlkji

Known  
 nmlkji

Not known  

  
 
123  .    

 

 nmlkji
x 109/L (x 103/mm3)  

 nmlkji
x 106/L  

 
 

124  Serum creatinine:

    
 nmlkji

Known  
 nmlkji

Not known  

  
 
125  .    

 

 nmlkji
mg/dL  

 nmlkji
mmol/L  

 nmlkji
µmol/L  

 
 

126  Creatinine clearance:

    
 nmlkji

Known  
 nmlkji

Not known  

  
 
127  .    

 

 nmlkji
mL/min  

 nmlkji
mL/sec  

  Laboratory Studies Prior to Mobilization for Stem Cell Collection Questions: 115 - 179

Form 2044 R2.0: Systemic Sclerosis Pre-HSCT Data  
Center:  CRID: 

                 CIBMTR Form 2044 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 8 / 17



 
 

128  Creatinine phosphokinase:

    
 nmlkji

Known  
 nmlkji

Not known  

  
 
129  .    

 

 nmlkji
U/L  

 nmlkji
µkat/L  

 
 

130  Blood urea nitrogen:

    
 nmlkji

Known  
 nmlkji

Not known  

  
 
131  .    

 

 nmlkji
mg/dL  

 nmlkji
mmol/L  

 
 

132  Was there evidence of hematuria prior to mobilization therapy for stem cell collection?

    
 nmlkji

yes, present  
 nmlkji

no, absent  
 nmlkji

Unknown  

 
 

133  Was there evidence of proteinuria prior to mobilization therapy for stem cell collection?

    
 nmlkji

yes, present  
 nmlkji

no, absent  
 nmlkji

Unknown  

 
 

134  Thyroid stimulating hormone (TSH):

    
 nmlkji

Known  
 nmlkji

Not known  

  
 
135  .    

 

 nmlkji
mU/L  

 nmlkji
μU/ml  

 
 

136  Was any testing for autoantibodies performed prior to mobilization for stem cell collection?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 

Specify the test results for the following autoantibodies: 
 

137  Anti-centromere:

    
 nmlkji

Positive  
 nmlkji

Negative  
 nmlkji

Inconclusive  
 nmlkji

not tested / unknown  

 
 

138  Anti-DNA topoi- 
somerase I (Scl-70):

    
 nmlkji

Positive  
 nmlkji

Negative  
 nmlkji

Inconclusive  
 nmlkji

not tested / unknown  

 
 

139  Anti-nuclear:

    
 nmlkji

Positive  
 nmlkji

Negative  
 nmlkji

Inconclusive  
 nmlkji

not tested / unknown  

 
 

140  Anti-SS-A:

    
 nmlkji

Positive  
 nmlkji

Negative  
 nmlkji

Inconclusive  
 nmlkji

not tested / unknown  

 
 

141  Anti-SS-B:

    
 nmlkji

Positive  
 nmlkji

Negative  
 nmlkji

Inconclusive  
 nmlkji

not tested / unknown  

 

Specify the results of the following pulmonary function tests performed prior to mobilization therapy for stem cell collection: 
 

142  Was dyspnea present on exertion?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

143  Vital capacity (VC):

    
 nmlkji

Known  
 nmlkji

Not known  

 
 
144  .    % (predicted value) 

 
 

145  Was the actual VC value in the normal range
(≥ 80 % of predicted value)? 

    
 nmlkji

yes  
 nmlkji

no  

 
 

146  DLCO:
    

 nmlkji
Known  

 nmlkji
Not known  

 
 
147  .    % (predicted value) 

Form 2044 R2.0: Systemic Sclerosis Pre-HSCT Data  
Center:  CRID: 

                 CIBMTR Form 2044 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 9 / 17



 
 

148  Was the actual DLCO value in the normal range
(>=80% or predicted value)? 

    
 nmlkji

yes  
 nmlkji

no  

 
 

149  DLCO corrected for hemoglobin
    

 nmlkji
Known  

 nmlkji
Not known  

 
 
150  .    % (predicted value) 

 
 

151  Was the DLCO value (corrected for hemoglobin) 
in the normal range (>=80% of predicted value)?

    
 nmlkji

yes  
 nmlkji

no  

 
 

152  Was oxygen desaturation present on excercize testing?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

153  Was ground glass appearance present on chest x-ray?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

154  Was a high resolution chest CT scan performed?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

155  Was ground glass appearance present on CT scan?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

156  Was bronchoalveolar lavage (BAL) performed?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

157  Was alveolitis present?

    
 nmlkji

yes  
 nmlkji

no  

 
 
158  Specify the highest percentage of neutrophils present in the

segments tested: 
   % 

 
 

159  Was pulmonary artery hypertension present?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

160  Specify the mean pulmonary artery pressure (PAP) level:

    
 nmlkji

Known  
 nmlkji

Unknown  

 
 
161  .    mm / Hg 

 
 

162  Specify the method used to examine the PAP level:

    
 nmlkji

echocardiogram  
 nmlkji

catheterization  

 
 

163  Was systemic hypertension present that required treatment?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 

Specify treatment(s) given for hypertension: 
 

164  ACE inhibitor

    
 nmlkji

yes  
 nmlkji

no  

 
 

165  Other antihypertensive therapy

    
 nmlkji

yes  
 nmlkji

no  

 
 
166  Specify antihypertensive therapy:    

 
 
167  Specify the duration of antihypertensive therapy:    months 

 
 

168  Was arrhythmia present that required treatment?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

Form 2044 R2.0: Systemic Sclerosis Pre-HSCT Data  
Center:  CRID: 

                 CIBMTR Form 2044 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 10 / 17



 
 

169  Was an echocardiogram performed prior to mobilization therapy for stem cell collection?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

170  Was pericardial effusion present?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

171  Specify the size of the area of accumulated excess fluid:

    
 nmlkji

small  
 nmlkji

moderate  
 nmlkji

large  

 
 

172  Specify the left ventricular ejection fraction:

    
 nmlkji

Known  
 nmlkji

Not known  

 
 
173  .    % 

 
 

174  Was a multiple gate acquisition scan (MUGA test / nuclear ventriculography) performed prior to mobilization therapy for stem cell collection?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 
175  Specify the left ventricular ejection fraction:    % 

 
176  Did the recipient complete a modified Health Assessment Questionnaire (HAQ) for Scleroderma prior to mobilazation therapy for stem cell collection? Steen VD, Medsger Jr. TA. 

The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 1997; 40 

(11): 1984-1991. 

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 
177  Recipient's score:    

 
 
178  Worst possible score:    

 
 
179  Best possible score:    

 

  

gfedcb
Information for this section should come from the most recent evaluation performed < 2 weeks prior to the preparative regimen. If the recipient was not evaluated prior to the 
preparative regimen, check here and continue with question 268. 

 
 
180  Date of evaluation prior to the preparative regimen: __ __ __ __ - __ __- __ __  

 
 

181  What was the extent of cutaneous systemic sclerosis prior to the start of the preparative regimen?

    
 nmlkji

limited (cutaneous thickening distal (but not proximal) to elbows or knees)  

 nmlkji
diffuse  

 nmlkji
Unknown  

 

Specify skin thickness for the following sites as determined by clinical palpation performed prior to the start of the preparative regimen: Clements P, Lachenbruch P, Seibold 

J, White B, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995; 22:1281-

1285.   
 

182  Face

    
 nmlkji

score 0   - Normal 

 nmlkji
score 1   - Mild 

 nmlkji
score 2   - Moderate 

 nmlkji
score 3   - Severe (inability to pinch skin into a fold) 

 
 

183  Anterior chest

    
 nmlkji

score 0   - Normal 

 nmlkji
score 1   - Mild 

 nmlkji
score 2   - Moderate 

 nmlkji
score 3   - Severe (inability to pinch skin into a fold) 

  Most Recent Disease Assessment Prior to the Start of the Preparative Regimen Questions: 180 - 212

Form 2044 R2.0: Systemic Sclerosis Pre-HSCT Data  
Center:  CRID: 

                 CIBMTR Form 2044 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 11 / 17



 
 

184  Abdomen

    
 nmlkji

score 0   - Normal 

 nmlkji
score 1   - Mild 

 nmlkji
score 2   - Moderate 

 nmlkji
score 3   - Severe (inability to pinch skin into a fold) 

 
 

185  Upper arm - left

    
 nmlkji

score 0   - Normal 

 nmlkji
score 1   - Mild 

 nmlkji
score 2   - Moderate 

 nmlkji
score 3   - Severe (inability to pinch skin into a fold) 

 
 

186  Upper arm - right

    
 nmlkji

score 0   - Normal 

 nmlkji
score 1   - Mild 

 nmlkji
score 2   - Moderate 

 nmlkji
score 3   - Severe (inability to pinch skin into a fold) 

 
 

187  Forearms - left

    
 nmlkji

score 0   - Normal 

 nmlkji
score 1   - Mild 

 nmlkji
score 2   - Moderate 

 nmlkji
score 3   - Severe (inability to pinch skin into a fold) 

 
 

188  Forearms - right

    
 nmlkji

score 0   - Normal 

 nmlkji
score 1   - Mild 

 nmlkji
score 2   - Moderate 

 nmlkji
score 3   - Severe (inability to pinch skin into a fold) 

 
 

189  Dorsum of hand - left

    
 nmlkji

score 0   - Normal 

 nmlkji
score 1   - Mild 

 nmlkji
score 2   - Moderate 

 nmlkji
score 3   - Severe (inability to pinch skin into a fold) 

 
 

190  Dorsum of hand - right

    
 nmlkji

score 0   - Normal 

 nmlkji
score 1   - Mild 

 nmlkji
score 2   - Moderate 

 nmlkji
score 3   - Severe (inability to pinch skin into a fold) 

Form 2044 R2.0: Systemic Sclerosis Pre-HSCT Data  
Center:  CRID: 

                 CIBMTR Form 2044 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 12 / 17



 
 

191  Fingers - left

    
 nmlkji

score 0   - Normal 

 nmlkji
score 1   - Mild 

 nmlkji
score 2   - Moderate 

 nmlkji
score 3   - Severe (inability to pinch skin into a fold) 

 
 

192  Fingers - right

    
 nmlkji

score 0   - Normal 

 nmlkji
score 1   - Mild 

 nmlkji
score 2   - Moderate 

 nmlkji
score 3   - Severe (inability to pinch skin into a fold) 

 
 

193  Thigh - left

    
 nmlkji

score 0   - Normal 

 nmlkji
score 1   - Mild 

 nmlkji
score 2   - Moderate 

 nmlkji
score 3   - Severe (inability to pinch skin into a fold) 

 
 

194  Thigh - right

    
 nmlkji

score 0   - Normal 

 nmlkji
score 1   - Mild 

 nmlkji
score 2   - Moderate 

 nmlkji
score 3   - Severe (inability to pinch skin into a fold) 

 
 

195  Lower leg - left

    
 nmlkji

score 0   - Normal 

 nmlkji
score 1   - Mild 

 nmlkji
score 2   - Moderate 

 nmlkji
score 3   - Severe (inability to pinch skin into a fold) 

 
 

196  Lower leg - right

    
 nmlkji

score 0   - Normal 

 nmlkji
score 1   - Mild 

 nmlkji
score 2   - Moderate 

 nmlkji
score 3   - Severe (inability to pinch skin into a fold) 

 
 

197  Dorsum of foot - left

    
 nmlkji

score 0   - Normal 

 nmlkji
score 1   - Mild 

 nmlkji
score 2   - Moderate 

 nmlkji
score 3   - Severe (inability to pinch skin into a fold) 

Form 2044 R2.0: Systemic Sclerosis Pre-HSCT Data  
Center:  CRID: 

                 CIBMTR Form 2044 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 13 / 17



 
 

198  Dorsum of foot - right

    
 nmlkji

score 0   - Normal 

 nmlkji
score 1   - Mild 

 nmlkji
score 2   - Moderate 

 nmlkji
score 3   - Severe (inability to pinch skin into a fold) 

 
 
199  Total modified Rodnan Skin Score: (add scores from questions 182-198)    

 

Specify the following clinical findings prior to the start of the preparative regimen: 
 

200  Changes in skin pigmentation:

    
 nmlkji

Present  
 nmlkji

Absent  
 nmlkji

Unknown  

 
 

201  Raynaud's phenomenon:

    
 nmlkji

Present  
 nmlkji

Absent  
 nmlkji

Unknown  

 
 

202  Painful digital ulcers:

    
 nmlkji

Present  
 nmlkji

Absent  
 nmlkji

Unknown  

 
 
203  Specify number of digital ulcers:    

 
 

204  Gut dysmotility:

    
 nmlkji

Present  
 nmlkji

Absent  
 nmlkji

Unknown  

 
 

205  Malabsorption:

    
 nmlkji

Present  
 nmlkji

Absent  
 nmlkji

Unknown  

 
 

206  Weight loss > 10% of body weight:

    
 nmlkji

Present  
 nmlkji

Absent  
 nmlkji

Unknown  

 
 

207  Muscle weakness:

    
 nmlkji

Present  
 nmlkji

Absent  
 nmlkji

Unknown  

 
 

208  Joint tenderness:

    
 nmlkji

Present  
 nmlkji

Absent  
 nmlkji

Unknown  

 
 
209  Specify number of joints affected:    

 
 

210  Tendon friction rubs:

    
 nmlkji

Present  
 nmlkji

Absent  
 nmlkji

Unknown  

 
 
211  Specify the number of sites affected:    

 
 

212  Contractures:

    
 nmlkji

Present  
 nmlkji

Absent  
 nmlkji

Unknown  

 
 
213  Date lab studies were performed: __ __ __ __ - __ __- __ __  

 
 

214  Creatinine clearance:

    
 nmlkji

Known  
 nmlkji

Not known  

  
 
215  .    

 

 nmlkji
mL/min  

 nmlkji
mL/sec  

 
 

216  Creatinine phosphokinase:

    
 nmlkji

Known  
 nmlkji

Not known  

  
 
217  .    

 

 nmlkji
U/L  

 nmlkji
µkat/L  

  Laboratory Studies Prior to the Start of the Preparative Regimen Questions: 213 - 263

Form 2044 R2.0: Systemic Sclerosis Pre-HSCT Data  
Center:  CRID: 

                 CIBMTR Form 2044 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 14 / 17



 
 

218  Blood urea nitrogen:

    
 nmlkji

Known  
 nmlkji

Not known  

  
 
219  .    

 

 nmlkji
mg/dL  

 nmlkji
mmol/L  

 
 

220  Was there evidence of hematuria prior to the start of the preparative regimen?

    
 nmlkji

yes, present  
 nmlkji

no, absent  
 nmlkji

Unknown  

 
 

221  Was there evidence of proteinuria prior to the start of the preparative regimen?

    
 nmlkji

yes, present  
 nmlkji

no, absent  
 nmlkji

Unknown  

 
 

222  Thyroid stimulating hormone (TSH):

    
 nmlkji

Known  
 nmlkji

Not known  

  
 
223  .    

 

 nmlkji
mU/L  

 nmlkji
μU/ml  

 
 

224  Was any testing for autoantibodies performed prior to the start of the preparative regimen?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 

Specify the test results for the following autoantibodies: 
 

225  Anti-centromere:

    
 nmlkji

Positive  
 nmlkji

Negative  
 nmlkji

Inconclusive  
 nmlkji

not tested / unknown  

 
 

226  Anti-DNA topoisomerase I (Scl-70):

    
 nmlkji

Positive  
 nmlkji

Negative  
 nmlkji

Inconclusive  
 nmlkji

not tested / unknown  

 
 

227  Anti-nuclear:

    
 nmlkji

Positive  
 nmlkji

Negative  
 nmlkji

Inconclusive  
 nmlkji

not tested / unknown  

 
 

228  Anti-SS-A:

    
 nmlkji

Positive  
 nmlkji

Negative  
 nmlkji

Inconclusive  
 nmlkji

not tested / unknown  

 
 

229  Anti-SS-B:

    
 nmlkji

Positive  
 nmlkji

Negative  
 nmlkji

Inconclusive  
 nmlkji

not tested / unknown  

 

Specify the results of the following pulmonary function tests performed prior to the start of the preparative regimen: 
 

230  Was dyspnea present on exertion?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

231  Vital capacity (VC):

    
 nmlkji

Known  
 nmlkji

Not known  

 
 
232  .    % (predicted value) 

 
 

233  Was the actual VC value in the normal range
(>= 80% of predicted value)? 

    
 nmlkji

yes  
 nmlkji

no  

 
 

234  DLCO:
    

 nmlkji
Known  

 nmlkji
Not known  

 
 
235  .    % (predicted value) 

 
 

236  Was the actual DLCO: value in the normal range
(>= 80% of the predicted value)? 

    
 nmlkji

yes  
 nmlkji

no  

Form 2044 R2.0: Systemic Sclerosis Pre-HSCT Data  
Center:  CRID: 

                 CIBMTR Form 2044 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 15 / 17



 
 

237  DLCO corrected for hemoglobin:
    

 nmlkji
Known  

 nmlkji
Not known  

 
 
238  .    % (predicted value) 

 
 

239  Was the DLCO value (corrected for hemoglobin) 
in the normal range (>= 80% of predicted value)?

    
 nmlkji

yes  
 nmlkji

no  

 
 

240  Was oxygen desaturation present on exercise testing?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

241  Was ground glass appearance present on chest x-ray?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

242  Was a high resolution chest CT performed?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

243  Was ground glass appearance present on CT scan?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

244  Was bronchoalveolar lavage (BAL) performed?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

245  Was alveolitis present?

    
 nmlkji

yes  
 nmlkji

no  

 
 
246  Specify the highest percentage of neutrophils present in the segments tested:    % 

 
 

247  Was pulmonary artery hypertension present?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

248  Specify the mean pulmonary artery pressure (PAP) level:

    
 nmlkji

Known  
 nmlkji

Not known  

 
 
249  .    mm / Hg 

 
 

250  Specify the method used to examine the PAP level:

    
 nmlkji

echocardiogram  
 nmlkji

catheterization  

 
 

251  Was systemic hypertension present that required treatment?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 

Specify treatment(s) given for hypertension: 
 

252  ACE inhibitor

    
 nmlkji

yes  
 nmlkji

no  

 
 

253  Other antihypertensive therapy

    
 nmlkji

yes  
 nmlkji

no  

 
 
254  Specify antihypertensive therapy:    

 
 
255  Specify the duration of antihypertensive therapy:    months 

 
 

256  Was arrhythmia present that required treatment?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

257  Was an echocardiogram performed prior to the start of the preparative regimen?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

Form 2044 R2.0: Systemic Sclerosis Pre-HSCT Data  
Center:  CRID: 

                 CIBMTR Form 2044 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 16 / 17



 
 

258  Was pericardial effusion present?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

259  Specify the size of the area of accumulated excess fluid:

    
 nmlkji

small  
 nmlkji

moderate  
 nmlkji

large  

 
 

260  Specify the left ventricular ejection fraction:

    
 nmlkji

Known  
 nmlkji

Not known  

 
 
261  .    % 

 
 

262  Was a multiple gate acquisition scan (MUGA test / nuclear ventriculography) performed prior to the start of the preparative regimen?

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 
263  Sepcify the left ventricular ejection fraction:    % 

 
264  Did the recipient complete a modified Health Assessment Questionnaire (HAQ) for Scleroderma prior to the start of the preparative regimen? Steen VD, Medsger Jr. TA. The value 

of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 1997; 40 (11): 1984-

1991. 

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 
265  Recipient's score:    

 
 
266  Worst possible score:    

 
 
267  Best possible score:    

 

Specify the site(s) of disease involvement which were included in the primary indication(s) to proceed with HSCT: 
 

268  Gastrointestinal (GI) tract

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

269  Heart

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

270  Lungs

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

271  Severe functional impairment

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

272  Skin

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 

273  Other site of disease

    
 nmlkji

yes  
 nmlkji

no  
 nmlkji

Unknown  

 
 
274  Specify site of disease:    

  
 
First Name:    

 
Last Name:    

  
 
Phone number:    

 
Fax number:    

 
 
E-mail address:    

  Functional Assessment Prior to the Start of the Preparative Regimen Questions: 264 - 274

Form 2044 R2.0: Systemic Sclerosis Pre-HSCT Data  
Center:  CRID: 

                 CIBMTR Form 2044 revision 2.0 last updated July 2007
Copyright(c) 2012 National Marrow Donor Program and  

The Medical College of Wisconsin, Inc. All rights reserved.  Page 17 / 17